Objectives: Postmenopausal women with type 2 diabetes mellitus (T2DM) face metabolic, endocrine, and psychosocial challenges that heighten distress; resilience and hope may mitigate these.Their interrelationship and predictors remain unclear.We examined the resilience-hope correlation and determinants in postmenopausal T2DM women.Methods: This single-center cross-sectional study enrolled 283 postmenopausal T2DM women via convenience sampling from a tertiary hospital in Tehran, Iran.Instruments included a demographic/clinical questionnaire, the Connor-Davidson Resilience Scale, and the Miller Hope Scale.Spearman's correlation and multiple linear regression (enter) identified predictors (P < 0.05).Results: Mean hope and resilience scores were 147.5 ± 13.1 and 77.6 ± 7.3 (moderate).Hope and resilience showed a strong positive correlation (r s = 0.790, P < 0.01); the "control and meaning of life" dimension had the strongest association (r s = 0.503, P < 0.01).Housekeeper status (B = -0.168,P = 0.001) and current medication use (B = -0.087,P = 0.007) independently predicted lower hope.No predictor emerged for resilience.Diabetes and menopause duration were non-significant.Conclusions: Resilience and hope are strongly interrelated in this population.Psychosocial factors occupational engagement and perceived medication burden outweigh biological milestones.Routine psychosocial assessment and interventions that strengthen personal agency and social integration may fortify both constructs.Prospective research is needed to confirm causality.
No takes yet. Share an insight, caveat, or question.
Tabatabaei et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: